β-Adrenergic Receptors in Cancer: Therapeutic Implications

Abstract

The beta-adrenergic receptors transduce catecholamine signals to the G protein, which through a cascade of chemical reactions in cells generates highly specific parallel signals. The beta2-adrenergic receptor (ADRB2) is the most involved in the carcinogenic processes. Previous studies have determined the relationship of ADRB2 with various aspects related to cancer. Basically, it seems to be related with cell proliferation and apoptosis, chemotaxis, development of metastasis and tumor growth, and angiogenesis. The purpose of this review is to update the implications of these receptors in the pathogenesis of cancer and study the possible application of agonist drugs and/or antagonists in antitumor therapy.

Spinal Anesthesia Does Not Impact Prostate Cancer Recurrence in a Cohort of Men Undergoing Radical Prostatectomy

“…1 As an adjunct to general endotracheal anesthesia, regional anesthesia can decrease volatile anesthestic requirements, (2, 3) decrease opioid requirements, (4, 5) block activation of the sympathetic nervous system, (6, 7) attenuate immunosuppression, (8, 9) improve tissue oxygenation, (3, 10) decrease post-operative pain (11) , and promote innate anti-tumor factors through the effects of local anesthetic. (2) …”

Fundamental Principles of Cancer Biology: Does It Have Relevance to the Perioperative Period?

“…Retrospective studies implicate neuroendocrine mediators, such as catecholamines and prostaglandins. Many different malignancies express receptors for catecholamines [62] and prostaglandins [63] exerting a direct tumoral effect, which includes promotion of tumor-cell proliferation [64], adhesion [65], migration [66] and invasion [64], resistance to apoptosis and anoikis [67, 68], as well as secretion of pro-angiogenic factors such as vascular endothelial growth factor [69]. Again the indirect mechanism of suppression of perioperative anti-metastatic immunity exists [44].…”

Are Beta Blockers New Potential Anticancer Agents?

“…It has been observed that all cancers on which β-blockers have shown a suppressive effect express β-ARs (Perez-Sayans et al, 2010). β-ARs signaling pathways play a significant role in cell proliferation, differentiation and cell migration (Herlenius and Lagercrantz, 2001;Kim et al, 2008).…”